Expediting Antibody Discovery with a Cell and Bead Multiplexed

A high-throughput, multiplexed cell and bead-based competition assay that identifies and quantitates mouse IgG isotypes and assesses cell health is developed that can reduce the time to antibody cloning and production. With advances in molecular engineering and humanization, monoclonal antibodies are one of the fastest-growing classes of biopharmaceuticals. During antibody discovery, antibody from hybridoma or primary B-cell supernatants is screened for the desired binding characteristics, and secondary screens measure antibody function and concentration, identify immunoglobulin G (IgG) isotype, and assess cell health. In order to expedite the antibody discovery process, we developed a high-throughput, multiplexed cell and bead-based competition assay that identifies and quantitates mouse IgG isotypes and assesses cell health. No differences in assay performance were observed between single and multiplex formats. The linear range of the assay was from 0.5 to 50 µg/mL, and washing was not required, decreasing assay time and variability. Slight modifications to the protocol allowed quantification of dilute antibody supernatants (0.1–5 µg/mL). Using hybridoma cultures, we showed that cell viability measurements in the assay did not interfere with the bead-based IgG measurements. The assay described here is a simple mix-and-read, no-dilution screen that can reduce the time to antibody cloning and production. The high-content data can differentiate monoclonal and polyclonal wells, determine IgG quantity for downstream functional assays, provide isotype information, and monitor cell proliferation and viability.

Selecting the Right Platform for Your Antibody Discovery Project

The Role of Single-Cell Profiling and Deep Immunophenotyping in

Zhaoping Liu

Expediting Antibody Discovery with a Cell and Bead Multiplexed

Multiplex Cytokine Immunoassays

Characterization of antibodies from the established hybridomas by

Expediting Antibody Discovery with a Cell and Bead Multiplexed

Expediting Antibody Discovery with a Cell and Bead Multiplexed

Low-Cost and Scalable Platform with Multiplexed Microwell Array

Expediting Antibody Discovery with a Cell and Bead Multiplexed

A cell-based multiplex immunoassay platform using fluorescent

Single-cell sequencing of plasma cells from COVID-19 patients

ELISA in the multiplex era: Potentials and pitfalls – topic of

Automated High-Throughput Flow Cytometry for High-Content